Alternative mechanisms of action of anti-oestrogens
- 1 January 1994
- journal article
- review article
- Published by Springer Science and Business Media LLC in Breast Cancer Research and Treatment
- Vol. 31 (1), 5-9
- https://doi.org/10.1007/bf00689672
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Inhibition of Metastatic Behavior of Murine Osteosarcoma by HypophysectomyJNCI Journal of the National Cancer Institute, 1992
- Desmoid tumours treated with triphenylethylenesEuropean Journal of Cancer, 1992
- Tamoxifen reduces serum insulin-like growth factor I (IGF-I)Breast Cancer Research and Treatment, 1992
- Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy: 133 randomised trials involving 31 000 recurrences and 24 000 deaths among 75 000 womenThe Lancet, 1992
- Primary medical therapy for operable breast cancerEuropean Journal of Cancer and Clinical Oncology, 1989
- Regulation of gene expression by nuclear hormone receptorsCurrent Opinion in Cell Biology, 1989
- Nuclear receptors enhance our understanding of transcription regulationTrends in Genetics, 1988
- Insulin-like growth factors stimulate chemotaxis in human melanoma cellsBiochemical and Biophysical Research Communications, 1988
- Definition of two distinct mechanisms of action of antiestrogens on human breast cancer cell proliferation using hydroxytriphenylethylenes with high affinity for the estrogen receptorBiochemical and Biophysical Research Communications, 1986
- Tamoxifen is a calmodulin antagonist in the activation of cAMP phosphodiesteraseBiochemical and Biophysical Research Communications, 1984